pAD

There are 2 papers on pAD in aging research: 1 observational study in people.

Biomarker

2 papers study it7 findings

See all 2 papers on pAD

“The p AD hazard ratios [95% CI] were 3.58 [2.79,4.61], 4.67 [3.46,6.30] and 4.35 [3.34,5.67] for models trained on NACC, ADNI and both datasets respectively”
Neuroimaging‐based artificial intelligence for predicting dementia progression in a diverse real‐world memory clinic cohortAAIC 2025 abstract2025doi:10.1002/alz70863_110618
  • Humans1
  • In silico1

Upstream

3

Amyloid

upin humans1

1 study
  1. Amyloid is linked with higher pAD in patients with aMCI (2.40 ± 5.25 vs 0.93 ± 5.20; P = .003).

    “patients with amyloid-positive aMCI were observed to have higher PADs than patients with amyloid-negative status”

    Humansin patients with aMCI

    Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression

    Radiology. Artificial intelligence

More on Amyloid

APOE

upin humans1

1 study
  1. APOE is linked with higher pAD in patients with aMCI (3.76 ± 4.82 vs 0.10 ± 5.05; P = .017).

    “apolipoprotein E ε4 allele carriers were observed to have higher PADs than noncarriers”

    Humansin patients with aMCI

    Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression

    Radiology. Artificial intelligence

More on APOE

Amnestic mild cognitive impairment

upin humans1

1 study
  1. Amnestic mild cognitive impairment is linked with higher pAD in humans (patients with aMCI vs healthy controls) (BABRI: 2.65 ± 4.91 vs 0.18 ± 4.79 (P < .001); ADNI: 1.68 ± 5.28 vs 0.05 ± 4.41 (P < .001)).

    “patients with aMCI were found to have higher PADs than those of healthy controls”

    Humanspatients with aMCI vs healthy controls

    Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression

    Radiology. Artificial intelligence

More on Amnestic mild cognitive impairment

Associations

3

Dementia

upin humans1HR 3.58

1 study
  1. pAD is linked with a higher risk of dementia in humans (13.6%-16.7% increased risk per 0.1 increase).

    “with a 0.1 increase in p AD equating to a 13.6%‐16.7% increased risk of receiving a dementia diagnosis within 8 years.”

    Humansbrainwithin 8 yearsn = 1,140

    Neuroimaging‐based artificial intelligence for predicting dementia progression in a diverse real‐world memory clinic cohort

    AAIC 2025 abstract

  2. pAD predicts dementia in humans (models trained on NACC, ADNI and both datasets respectively) (HR 3.58 [2.79, 4.61]).

    “The p AD hazard ratios [95% CI] were 3.58 [2.79,4.61], 4.67 [3.46,6.30] and 4.35 [3.34,5.67] for models trained on NACC, ADNI and both datasets respectively”

    Humansmodels trained on NACC, ADNI and both datasets respectivelybrain8 yearsn = 1,140

    Neuroimaging‐based artificial intelligence for predicting dementia progression in a diverse real‐world memory clinic cohort

    AAIC 2025 abstract

More on Dementia

Clinical progression

upin humans1

1 study
  1. pAD predicts clinical progression in humans (for differentiating between progressive and stable aMCI) (AUC 0.87).

    “PAD combined with other markers of AD at baseline for differentiating between progressive and stable aMCI resulted in an area under the curve value of 0.87”

    Humansfor differentiating between progressive and stable aMCI

    Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression

    Radiology. Artificial intelligence

Cognitive impairment

upin humans1

1 study
  1. pAD is associated with cognitive impairment in patients with aMCI (P < .05, corrected).

    “the PAD was significantly associated with individual cognitive impairment in several cognitive domains in patients with aMCI”

    Humansin patients with aMCI

    Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression

    Radiology. Artificial intelligence

Funding

21 grants since 2017

National Heart, Lung, and Blood Institute$7.5MNational Institute on Aging$5MUS Department of Veterans Affairs

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months